These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Antibiotic resistance in gram-negative bacilli: a Singapore perspective. Tan TY, Hsu LY, Koh TH, Ng LS, Tee NW, Krishnan P, Lin RT, Jureen R. Ann Acad Med Singap; 2008 Oct; 37(10):819-25. PubMed ID: 19037514 [Abstract] [Full Text] [Related]
23. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan. Liu HY, Lin HC, Lin YC, Yu SH, Wu WH, Lee YJ. J Microbiol Immunol Infect; 2011 Oct; 44(5):364-8. PubMed ID: 21524974 [Abstract] [Full Text] [Related]
24. Patterns of Drug-Resistant Bacteria in a General Hospital, China, 2011-2016. Mao T, Zhai H, Duan G, Yang H. Pol J Microbiol; 2019 Oct; 68(2):225-232. PubMed ID: 31250593 [Abstract] [Full Text] [Related]
26. Evaluation of current activities of fluoroquinolones against gram-negative bacilli using centralized in vitro testing and electronic surveillance. Sahm DF, Critchley IA, Kelly LJ, Karlowsky JA, Mayfield DC, Thornsberry C, Mauriz YR, Kahn J. Antimicrob Agents Chemother; 2001 Jan; 45(1):267-74. PubMed ID: 11120976 [Abstract] [Full Text] [Related]
27. Antimicrobial resistance of gram-negative bacteria: A six-year longitudinal study in a hospital in Saudi Arabia. Al-Tawfiq JA, Rabaan AA, Saunar JV, Bazzi AM. J Infect Public Health; 2020 May; 13(5):737-745. PubMed ID: 32008927 [Abstract] [Full Text] [Related]
29. In vitro activity of fosfomycin and other antimicrobials against uropathogenic Escherichia coli and Klebsiella pneumoniae at a tertiary care center in Lebanon. Araj GF, Jaber FA. J Med Liban; 2012 May; 60(3):142-7. PubMed ID: 23198454 [Abstract] [Full Text] [Related]
33. Susceptibility trends and molecular characterization of Gram-negative bacilli associated with urinary tract and intra-abdominal infections in Jordan and Lebanon: SMART 2011-2013. Hayajneh WA, Hajj A, Hulliel F, Sarkis DK, Irani-Hakimeh N, Kazan L, Badal RE. Int J Infect Dis; 2015 Jun; 35():56-61. PubMed ID: 25917963 [Abstract] [Full Text] [Related]
34. Assessing the pharmacodynamic profile of intravenous antibiotics against prevalent Gram-negative organisms collected in Colombia. Villegas MV, Briceno DF, Ruiz SJ, Furtado GH, Nicolau DP. Braz J Infect Dis; 2011 Jun; 15(5):413-9. PubMed ID: 22230846 [Abstract] [Full Text] [Related]
39. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin. Cho YH, Jung SI, Chung HS, Yu HS, Hwang EC, Kim SO, Kang TW, Kwon DD, Park K. Int Urol Nephrol; 2015 Jul; 47(7):1059-66. PubMed ID: 26026972 [Abstract] [Full Text] [Related]